Scholarly Index
Ioannis Ntanasis‐Stathopoulos
National and Kapodistrian University of Athens; 9,465 total citations; 409 total publications; best world rank #46
National and Kapodistrian University of Athens
9,465Total citations
409Total publications
44H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| SARS-CoV-2 and COVID-19 Research | Lifetime | 997 | GR 8 | 96.99 |
| Multiple Myeloma Research and Treatments | Lifetime | 429 | GR 7 | 97.70 |
| Protein Degradation and Inhibitors | Lifetime | 578 | GR 5 | 96.03 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 46 | GR 3 | 99.40 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 367 | GR 4 | 98.41 |
| Peptidase Inhibition and Analysis | 2021-2025 | 74 | GR 3 | 98.18 |
| Protein Degradation and Inhibitors | 2021-2025 | 89 | GR 2 | 98.03 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 278 | GR 4 | 96.98 |
| Ubiquitin and proteasome pathways | 2021-2025 | 451 | GR 2 | 88.05 |
| Bone health and treatments | 2021-2025 | 232 | GR 5 | 89.65 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 535 | GR 5 | 90.53 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 346 | GR 8 | 88.32 |
| Cancer Mechanisms and Therapy | 2021-2025 | 427 | GR 6 | 82.55 |
| Hematological disorders and diagnostics | 2021-2025 | 501 | GR 5 | 63.30 |